Search results for "CIT"

showing 10 items of 22474 documents

Compte rendu de : Jesús Gascón Pérez, Alzar banderas contra su rey. La rebelión aragonesa de 1591 contra Felipe II

2011

Le livre de Jesús Gascón Pérez, Alzar banderas contra su rey. La rebelión aragonesa de 1591 contra Felipe II, propose un récit circonstancié et parfaitement documenté de la révolte qui secoua le royaume d’Aragon, et tout particulièrement la ville de Saragosse, au cours de l’année 1591. Le détonateur de l’insurrection fut l’arrivée en Aragon d’Antonio Pérez. L’ancien secrétaire de Philippe II, qui était poursuivi pour crime de lèse-majesté en Castille, tenta de se mettre à l’abri de la justice...

révolteroyaume d'Aragon[SHS.LANGUE] Humanities and Social Sciences/Linguisticsrécit
researchProduct

3,5-Dimethoxy-4'-methylbiphenyl

2013

The title compound, C15H16O2, crystallizes with three independent mol­ecules in the asymmetric unit. The intra­molecular torsion angle between the aromatic rings of each mol­ecule are −36.4 (3), 41.3 (3) and −37.8 (3)°. In the crystal, the complicated packing of the mol­ecules forms wave-like layers along the b and c axes. The mol­ecules are connected via extensive meth­oxy–phenyl C—H…π inter­actions. A weak C—H…O hydrogen-bonding network also exists between meth­oxy O atoms and aromatic or meth­oxy H atoms.

röntgendiffraktiocrystal structuredendrimeeri prekursori010405 organic chemistryChemistryX-ray DiffractionAromaticitykiderakenneGeneral ChemistryDihedral angle010402 general chemistryCondensed Matter PhysicsBioinformaticsOrganic Papers01 natural sciences0104 chemical sciences3. Good healthCrystalCrystallographydendrimer precursorGeneral Materials Scienceta116
researchProduct

3,4-Dimethoxy-4'-methylbiphenyl

2013

In the title compound, C15H16O2, the dihedral angle between the planes of the aromatic rings is 30.5 (2). In the crystal, molecules are linked via C—HO hydrogen bonds and C— H interactions, forming a two-dimensional network lying parallel to (100). peerReviewed

röntgendiffraktiocrystal structuredendrimeeri prekursori010405 organic chemistryHydrogen bondChemistryAromaticitykiderakenneGeneral ChemistryDihedral angle010402 general chemistryCondensed Matter Physics01 natural sciencesOrganic PapersX-ray diffraction0104 chemical sciences3. Good healthCrystalCrystallographydendrimer precursorGeneral Materials Scienceta116Acta Crystallographica Section E-Structure Reports Online
researchProduct

Rēzus negatīvas grūtnieces antenatālas un agrīnas pēcdzemdību perioda aprūpes analīze Latvijā

2015

Katrā desmitajā rēzus negatīvajā grūtniecībā, māte ir rēzus negatīva, bet auglis rēzus pozitīvs, kas potenciāli predisponē rēzus D izosensibilizācijai. Adekvāta antenatāla un agrīna pēcdzemdību profilakse samazina izosensibilizācijas sastopamību. Pētījumā tika izanalizētas grūtnieču antivielu titri pret D antigēniem un imunizācija antenatālā un agrīnā pēcdzemdību periodā, rēzus negatīvo māšu grupā Latvijā 2012.gadā. Retrospektīvā pētījumā, piecu Latvijas reģionu slimnīcās, tika aplūkotas 75,67% (n=14682) dzemdību nodaļu vēstures no dzemdībam 2012.gadā Latvijā. Tika apkopota informācija par 2052 rēzus negatīvajām grūtniecēm. Reģioni tika salīdzināti savā starpā. Sešas dzemdētāju vēstures ar …

rēzus negatīva grūtniecībaantieritrocitāras antivielasantenatāla un agrīna pēcdzemdību aprūpeanti D imunoglobulīna profilakseMedicīna
researchProduct

Quand la communication publicitaire se pare de religiosité… au cœur d’instances religieuses profanées par la publicité

2014

International audience; Les frontières du profane et du sacré dans les stratégies publicitaires (discours et images) sont revisitées à partir d’exemples concrets empruntés à la communication publicitaire, qu’elle soit laïque ou religieuse. L'article met en lumière la distinction entre « communication par la foi », de « la communication de la foi » et s'interroge sur le passage entre communication sacrée et profane.De nouvelles formes de médiations être l'individuel et le social s'installent qui émergent comme figure du sensible dans la communication.

sacrécommunicationreligion[SHS.INFO]Humanities and Social Sciences/Library and information sciencesprofanemarketingsémiotique[ SHS.INFO ] Humanities and Social Sciences/Library and information sciencespublicité[SHS.INFO] Humanities and Social Sciences/Library and information sciences
researchProduct

Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in h…

2021

A quadrivalent high-dose inactivated influenza vaccine (IIV4-HD) is licensed for adults ≥65 y of age based on immunogenicity and efficacy studies. However, IIV4-HD has not been evaluated in adults aged 60–64 y. This study compared immunogenicity and safety of IIV4-HD with a standard-dose quadrivalent influenza vaccine (IIV4-SD) in adults aged ≥60 y. This Phase III, randomized, modified double-blind, active-controlled study enrolled 1,528 participants aged ≥60 y, randomized 1:1 to a single injection of IIV4-HD or IIV4-SD. Hemagglutination inhibition (HAI) geometric mean titers (GMTs) were measured at baseline and D 28 and seroconversion assessed. Safety was described for 180 d after vaccinat…

safetyAdultIMPACTInfluenza vaccineImmunologyimmunogenicityAntibodies ViralQuadrivalent Influenza Vaccineolder adultImmunogenicity VaccineDouble-Blind MethodInfluenza HumanMedicine and Health SciencesImmunology and AllergyMedicineHumansVaccines Combinedolder adultsPharmacologybusiness.industryImmunogenicityADULTSHemagglutination Inhibition TestsEFFICACYVirologyinfluenza vaccinationHigh-dose influenza vaccineVaccines InactivatedInfluenza VaccinesPhase III trialbusinessHuman vaccinesimmunotherapeutics
researchProduct

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study

2016

Purpose The PRAME tumour antigen is expressed in several tumour types but in few normal adult tissues. A dose-escalation phase I/II study (NCT01149343) assessed the safety, immunogenicity and clinical activity of the PRAME immunotherapeutic (recombinant PRAME protein (recPRAME) with the AS15 immunostimulant) in patients with advanced melanoma. Here, we report the phase I dose-escalation study segment. Patients and methods Patients with stage IV PRAME-positive melanoma were enrolled to 3 consecutive cohorts to receive up to 24 intramuscular injections of the PRAME immunotherapeutic. The RecPRAME dose was 20, 100 or 500 µg in cohorts 1, 2 and 3, respectively, with a fixed dose of AS15. Advers…

safetyCancer Researchmedicine.drug_classmedicine.medical_treatmentMedizinPhases of clinical research[SDV.CAN]Life Sciences [q-bio]/CancerimmunogenicityImmunostimulant03 medical and health sciences0302 clinical medicine[SDV.CAN] Life Sciences [q-bio]/CancerCancer immunotherapymedicine1506030304 developmental biologyOriginal ResearchPRAME antigen0303 health sciencesPRAMEcancer immunotherapybusiness.industryMelanomaImmunogenicityCancermedicine.disease3. Good healthOncology030220 oncology & carcinogenesisImmunologyChillsmedicine.symptombusinessmetastatic melanoma
researchProduct

Polyphenols and Pharmacological Screening of a Monarda fistulosa L. dry Extract Based on a Hydrodistilled Residue By-Product

2021

This study aimed to determine the composition and content of polyphenols in the dry extract obtained from the hydrodistilled residue by-product of the wild bergamot (Monarda fistulosa L., Lamiaceae Martinov family) herb (MFDE) and to evaluate its safety and pharmacological properties. The total phenolic content (TPC) in the MFDE was 120.64 mg GAE/g. The high-performance liquid chromatography (HPLC) analysis showed the presence of a plethora of phenolic compounds, including hydroxycinnamic acids and flavone derivatives in the MFDE, with rosmarinic acid and luteolin-7-O-glucoside being the main components. With an IC50 value of 0.285 mg/mL, it was found to be a strong DPPH radical scavenger. …

safetyDPPHRM1-950phenolic compoundsMonarda fistulosa01 natural sciencesHigh-performance liquid chromatographywild bergamot03 medical and health scienceschemistry.chemical_compound0302 clinical medicineantiradical activityPharmacology (medical)anti-inflammatory activityanalgesic activityOriginal ResearchPharmacologyResidue (complex analysis)biologyTraditional medicine010405 organic chemistryRosmarinic acidbiology.organism_classificationAcute toxicity0104 chemical scienceschemistryherbPolyphenol030220 oncology & carcinogenesispostdistillation wasteLamiaceaeTherapeutics. PharmacologyFrontiers in Pharmacology
researchProduct

A sustainable city environment through child safety and mobility:A challenge based on ITS?

2012

Our cities should be designed to accommodate everybody, including children. We will not move toward a more sustainable society unless we accept that children are people with transportation needs, and ‘bussing’ them around, or providing parental limousine services at all times, will not lead to sustainability. Rather, we will need to make our cities walkable for children, at least those above a certain age. Safety has two main aspects, traffic safety and personal safety (risk of assault). Besides being safe, children will also need an urban environment with reasonable mobility, where they themselves can reach destinations with reasonable effort; else they will still need to be driven. This p…

safetyEngineeringSafety ManagementAdolescentmedia_common.quotation_subjectPoison controlHuman Factors and ErgonomicsTransportationPedestrianWalkingViolenceOccupational safety and healthTransport engineering/dk/atira/pure/sustainabledevelopmentgoals/sustainable_cities_and_communitieschildrenResidence CharacteristicsSurveys and QuestionnairesHumansQuality (business)surveyMarketingCity PlanningSafety Risk Reliability and QualityChildmedia_commonSustainable developmentbusiness.industryintelligent transportation systemsPublic Health Environmental and Occupational HealthAccidents TrafficmobilitySDG 11 - Sustainable Cities and CommunitiesSustainable cityWalkabilityChild PreschoolSustainabilityEnvironment DesignSafetybusiness
researchProduct

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

2020

Funding: Transgène; International audience; Treatment of chronic hepatitis B (CHB) typically requires life-long administration of drugs. Cohort and pre-clinical studies have established the link between a functional T-cell-mounted immunity and resolution of infection. TG1050 is an adenovirus 5-based vaccine that expresses HBV polymerase and domains of core and surface antigen and has shown immunogenicity and antiviral effects in mice. We performed a phase 1 clinical trial to assess safety and explore immunogenicity and early efficacy of TG1050 in CHB patients. This randomized, double blind, placebo-controlled study included two sequential phases: one single dose cohort (SD, n = 12) and one …

safetyHBsAg030231 tropical medicineImmunologyPlacebo-controlled studyPhases of clinical researchSciences du Vivant [q-bio]/Médecine humaine et pathologieimmunogenicityPlaceboAntiviral AgentsAdenoviridae03 medical and health sciencesMice0302 clinical medicineHepatitis B ChronicImmunogenicity VaccinevaccineImmunology and AllergyMedicineAnimalsHumans030212 general & internal medicineAdverse effectPharmacologyVaccinesHepatitis B Surface Antigens[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologybusiness.industryELISPOTImmunogenicitychronicityimmuno-therapyHepatitis Bmedicine.diseaseHepatitis B3. Good healthImmunologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyResearch Paper
researchProduct